Humacyte, Inc.
Humacyte, Inc. (HUMA) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 141 transactions totaling $223.6M, demonstrating a bearish sentiment with -$129.0M in net insider flow. The most recent transaction on Nov 16, 2025 involved a transaction of 311,100 shares valued at $0.
HUMA Insider Activity Summary
Who Is Buying HUMA Stock?
No significant insider buying has been recorded for HUMA in the recent period.
Who Is Selling HUMA Stock?
No significant insider selling has been recorded for HUMA in the recent period.
Is Humacyte, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for HUMA is bearish with an Insider Alignment Score of 21/100 and a net flow of -$129.0M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
HUMA Frequently Asked Questions
Understanding HUMA Insider Activity
Insider trading at Humacyte, Inc. (HUMA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading HUMA stock, having executed 141 transactions in the past 90 days. The most active insider is Laura E. Niklason (Executive), who has made 42 transactions totaling $84.5M.
Related Tools
Track Humacyte, Inc. Insider Activity
Get notified when executives and directors at HUMA file new Form 4 transactions